These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19013366)

  • 1. Thalidomide-induced pneumonitis.
    Wyplosz B; Lerolle U; Israël-Biet D; Dougados J; Lillo-Le Louët A; Ghez D; Pouchot J
    Eur J Intern Med; 2008 Nov; 19(7):e57-8. PubMed ID: 19013366
    [No Abstract]   [Full Text] [Related]  

  • 2. Thalidomide-induced organizing pneumonia.
    Feaver AA; McCune DE; Mysliwiec AG; Mysliwiec V
    South Med J; 2006 Nov; 99(11):1292-4. PubMed ID: 17195429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients.
    Amraoui K; Belhadj K; Maître B; Jannière-Nartey C; Dupuis J
    Eur Respir Rev; 2013 Mar; 22(127):93-5. PubMed ID: 23457172
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible dementia due to thalidomide therapy for multiple myeloma.
    Morgan AE; Smith WK; Levenson JL
    N Engl J Med; 2003 May; 348(18):1821-2. PubMed ID: 12724497
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interstitial pneumonitis as an adverse effect of thalidomide].
    Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Jie KS
    Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 20051154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interstitial pneumonitis as an adverse effect of thalidomide].
    Scholte JB; Potjewijd J; Voogt PJ; Custers FL; Lie KS
    Ned Tijdschr Geneeskd; 2009; 153():A452. PubMed ID: 19785872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of thalidomide-induced interstitial pneumonia].
    Matsushima H; Oda T; Yamamoto M; Sato A; Hasejima N; Takezawa S
    Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):438-42. PubMed ID: 19514509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous sinus thrombosis in a patient taking thalidomide.
    Lenz RA; Saver J
    Cerebrovasc Dis; 2004; 18(2):175-7. PubMed ID: 15256794
    [No Abstract]   [Full Text] [Related]  

  • 9. Thalidomide and thrombosis.
    Mehta P
    Clin Adv Hematol Oncol; 2003 Aug; 1(8):464-5. PubMed ID: 16258433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quincke's edema and hypersensitivity pneumonitis induced by lenalidomide for multiple myeloma].
    Hatsuse M; Odaira E; Fuchida SI; Okano A; Murakami S; Shimazaki C
    Rinsho Ketsueki; 2016; 57(12):2502-2506. PubMed ID: 28090017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of thrombophylic states in myeloma patients receiving thalidomide: a reasonable doubt.
    Santos AB; Llamas P; Román A; Prieto E; De Oña R; De Velasco JF; Tomás JF
    Br J Haematol; 2003 Jul; 122(1):159-60. PubMed ID: 12823358
    [No Abstract]   [Full Text] [Related]  

  • 12. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
    Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M
    Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary toxicity associated with pomalidomide.
    Gajic S; Callahan EC; Brown JK; Elicker B; Ley B; Blanc PD
    Int J Tuberc Lung Dis; 2018 Nov; 22(11):1383-1386. PubMed ID: 30355421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension related to thalidomide therapy in refractory multiple myeloma.
    Antonioli E; Nozzoli C; Gianfaldoni G; Mannelli F; Rossi S; Betti S; Bernardeschi P; Fiorentini G; Bosi A
    Ann Oncol; 2005 Nov; 16(11):1849-50. PubMed ID: 16012178
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
    Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
    Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thalidomide for the treatment of refractory multiple myeloma].
    Kakimoto T; Hattori Y; Okamoto S
    Rinsho Ketsueki; 2002 May; 43(5):345-8. PubMed ID: 12096483
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thalidomide and others: new treatment for myeloma].
    Malphettes M; Fermand JP
    Rev Prat; 2003 Oct; 53(15):1633-5. PubMed ID: 14689905
    [No Abstract]   [Full Text] [Related]  

  • 18. Encephalopathy in a patient after long-term treatment with thalidomide.
    Sohlbach K; Heinze S; Shiratori K; Sure U; Pagenstecher A; Neubauer A
    J Clin Oncol; 2006 Oct; 24(30):4942-4. PubMed ID: 17050881
    [No Abstract]   [Full Text] [Related]  

  • 19. Thalidomide-associated arterial thrombosis: two case reports.
    Altintas A; Ayyildiz O; Atay AE; Cil T; Isikdogan A; Muftuoglu E
    Ann Acad Med Singap; 2007 Apr; 36(4):304-6. PubMed ID: 17483863
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide in multiple myeloma.
    Rajkumar SV
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 13):11-6. PubMed ID: 11204667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.